SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 60 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,477,000 | +0.5% | 8,173,937 | -0.9% | 1.28% | -19.8% |
| Q1 2016 | $4,455,000 | -39.8% | 8,250,000 | 0.0% | 1.60% | -48.5% |
| Q4 2015 | $7,404,000 | +181.2% | 8,250,000 | +153.8% | 3.11% | +198.5% |
| Q3 2015 | $2,633,000 | -65.6% | 3,250,000 | +27.9% | 1.04% | -65.1% |
| Q2 2015 | $7,650,000 | +200.6% | 2,541,459 | +144.7% | 2.98% | +166.2% |
| Q1 2015 | $2,545,000 | -10.9% | 1,038,652 | +159.7% | 1.12% | -8.7% |
| Q3 2014 | $2,856,000 | +123.3% | 400,000 | +106.6% | 1.23% | +83.7% |
| Q1 2014 | $1,279,000 | – | 193,567 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |